Dosing & Uses
Allogenic-HSCT Conditioning
Pending FDA approval for allogenic hematopoietic stem cell transplantation (HSCT) conditioning in combination with fludarabine
Next:
Pharmacology
Mechanism of Action
Prodrug of sulfonate alkylating agent that elicits myeloablative, immunosuppressive, and antineoplastic activities
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
